Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong.
Philips Healthcare, Hong Kong.
Neuroimage Clin. 2018 Jul 27;20:365-373. doi: 10.1016/j.nicl.2018.07.028. eCollection 2018.
Late stage Parkinson's disease (PD) patients were commonly observed with other non-motor comorbidities such as dementia and psychosis. While abnormal iron level in the substantia nigra was clinically accepted as a biomarker of PD, it was also suggested that the increased iron deposition could impair other brain regions and induce non-motor symptoms. A new Magnetic Resonance Imaging (MRI) called Quantitative Susceptibility Mapping (QSM) has been found to measure iron concentration in the grey matter reliably. In this study, we investigated iron level of different subcortical and limbic structures of Parkinson's disease (PD) patients with and without dementia by QSM. QSM and volumetric analysis by MRI were performed in 10 PD dementia (PDD) patients (73 ± 6 years), 31 PD patients (63 ± 8 years) and 27 healthy controls (62 ± 7 years). No significant differences were observed in the L-Dopa equivalent dosage for the two PD groups (p = 0.125). Putative iron content was evaluated in different subcortical and limbic structures of the three groups, as well as its relationship with cognitive performance. One-way ANCOVA with FDR adjustment at level of 0.05, adjusted for age and gender, showed significant group differences for left and right hippocampus (p = 0.015 & 0.032, respectively, BH-corrected for multiple ROIs) and right thalamus (p = 0.032, BH-corrected). Post-hoc test with Bonferroni's correction suggested higher magnetic susceptibility in PDD patients than healthy controls in the left and right hippocampus (p = 0.001 & 0.047, respectively, Bonferroni's corrected), while PD patients had higher magnetic susceptibility than the healthy controls in right hippocampus and right thalamus (p = 0.006 & 0.005, respectively, Bonferroni's corrected). PDD patients also had higher susceptibility than the non-demented PD patients in left hippocampus (p = 0.046, Bonferroni's corrected). The magnetic susceptibilities of the left and right hippocampus were negatively correlated with the Mini-Mental State Examination score ( = -0.329 & -0.386, respectively; p < 0.05). This study provides support for iron accumulation in limbic structures of PDD and PD patients and its correlation with cognitive performance, however, its putative involvement in development of non-motor cognitive dysfunction in PD pathogenesis remains to be elucidated.
晚期帕金森病 (PD) 患者常伴有其他非运动性共病,如痴呆和精神病。虽然黑质中的铁异常水平被临床认为是 PD 的生物标志物,但也有研究表明,铁沉积增加会损害其他脑区并引起非运动症状。一种新的磁共振成像 (MRI) 技术,定量磁化率映射 (QSM),已被发现可可靠地测量灰质中的铁浓度。在这项研究中,我们通过 QSM 研究了伴有和不伴有痴呆的帕金森病 (PD) 患者的不同皮质下和边缘结构的铁水平。在 10 名帕金森病痴呆 (PDD) 患者 (73 ± 6 岁)、31 名帕金森病患者 (63 ± 8 岁) 和 27 名健康对照者 (62 ± 7 岁) 中进行了 QSM 和 MRI 容积分析。两组 PD 患者的左旋多巴等效剂量无显著差异 (p = 0.125)。在三组不同的皮质下和边缘结构中评估了潜在的铁含量,并评估了其与认知表现的关系。采用 FDR 调整的单因素方差分析,调整年龄和性别,左、右海马体差异有统计学意义 (p = 0.015 和 0.032,BH 校正多个 ROI) 和右丘脑 (p = 0.032,BH 校正)。Bonferroni 校正后的后验检验提示 PDD 患者的左、右海马体的磁化率高于健康对照组 (p = 0.001 和 0.047,Bonferroni 校正),而 PD 患者的右海马体和右丘脑的磁化率高于健康对照组 (p = 0.006 和 0.005,Bonferroni 校正)。PDD 患者的左海马体磁化率也高于非痴呆 PD 患者 (p = 0.046,Bonferroni 校正)。左、右海马体的磁化率与简易精神状态检查评分呈负相关 ( = -0.329 和 -0.386,分别;p < 0.05)。这项研究为 PDD 和 PD 患者边缘结构的铁积累及其与认知表现的相关性提供了支持,然而,其在 PD 发病机制中非运动性认知功能障碍发展中的潜在作用仍有待阐明。